Swiss offer Geneva space for WHO pathogen exchange
Switzerland has offered secure space for the Geneva-based WHO to store pathogen materials as part of a proposed new global mechanism for sharing pathogens in the fight against Covid-19.
This content was published on
2 minutes
Keystone-SDA/Reuters/jc
“The pandemic has shown that there is an urgent need for a globally agreed system for sharing pathogen materials and clinical samples, to facilitate the rapid development of medical countermeasures as global public goods,” World Health Organization director-general Tedros Ghebreyesus said on Friday.
Speaking in closing remarks to a virtual WHO Assembly, he stressed this was needed quickly.
The WHO is proposing “a new approach that would include a repository for materials housed by WHO in a secure Swiss facility; an agreement that sharing materials into this repository is voluntary; that WHO can facilitate the transfer and use of the materials; and a set of criteria under which WHO would distribute them”.
Ghebreyesus said a number of countries had shown interest. He thanked Swiss health minister Alain Berset and the federal government “for offering a BSL 4 lab to support this initiative”.
COVAX on track
Meanwhile, the COVAX vaccine pool led by WHO and the Gavi Vaccine Alliance said on Friday it has exceeded its interim target of raising more than $2 billion (CHF1.83 billion) to buy and distribute Covid-19 vaccines for poorer countries.
These funds will allow COVAX to buy an initial one billion vaccine doses for 92 eligible countries that would not otherwise be able to afford them, according to a Gavi statement. But it said a further $5 billion will be needed in 2021 to buy Covid-19 vaccine doses as they come through development and are approved by regulators.
Gavi chief Seth Berkley also told journalists on Friday that US drugmaker Pfizer and its partner BioNTech, who this week said their Covid-19 vaccine was 90% effective in initial trials, had expressed interest in supplying doses to COVAX.
This content was published on
Nemo brought the Eurovision Song Contest to Switzerland with a victory on Saturday evening in Malmö, Sweden. It is Switzerland's third victory in the history of the music contest.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
This content was published on
Switzerland confirms participation in WHO COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.